The results of another study showed that only E-cadherin and P-cadherin immunochemistry may help predict prognosis in patients with early-stage cervical squamous cell carcinoma because of the very low expression of N-cadherin in cervical lesions, which is not associated with patient survival [37]. The gene discussed is CDH3; the disease is cervical squamous cell carcinoma.